| The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis MH Rozenbaum, P Pechlivanoglou, TS Van Der Werf, JR Lo-Ten-Foe, ... European journal of clinical microbiology & infectious diseases 32, 305-316, 2013 | 171 | 2013 |
| Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: a nationwide retrospective claims database analysis MH Rozenbaum, MJJ Mangen, SM Huijts, TS van der Werf, MJ Postma Vaccine 33 (28), 3193-3199, 2015 | 158 | 2015 |
| Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands MJJ Mangen, MH Rozenbaum, SM Huijts, CH van Werkhoven, ... European Respiratory Journal 46 (5), 1407-1416, 2015 | 154 | 2015 |
| Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 … MH Rozenbaum, EAM Sanders, AJ van Hoek, AGSC Jansen, ... Bmj 340, 2010 | 147 | 2010 |
| Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines S Vegter, C Boersma, M Rozenbaum, B Wilffert, GJ Navis, MJ Postma Pharmacoeconomics 26, 569-587, 2008 | 115 | 2008 |
| Underascertainment of respiratory syncytial virus infection in adults due to diagnostic testing limitations: a systematic literature review and meta-analysis C Onwuchekwa, LM Moreo, S Menon, B Machado, D Curcio, W Kalina, ... The Journal of infectious diseases 228 (2), 173-184, 2023 | 100 | 2023 |
| The impact of patent expiry on drug prices: a systematic literature review GT Vondeling, Q Cao, MJ Postma, MH Rozenbaum Applied health economics and health policy 16, 653-660, 2018 | 98 | 2018 |
| Stem cell-related cardiac gene expression early after murine myocardial infarction S Vandervelde, MJA van Luyn, MH Rozenbaum, AH Petersen, RA Tio, ... Cardiovascular research 73 (4), 783-793, 2007 | 97 | 2007 |
| Burden of early, advanced and metastatic breast cancer in The Netherlands GT Vondeling, GL Menezes, EP Dvortsin, FGA Jansman, IR Konings, ... BMC cancer 18, 1-11, 2018 | 94 | 2018 |
| Until which age should women be vaccinated against HPV infection? Recommendation based on cost-effectiveness analyses TA Westra, MH Rozenbaum, RM Rogoza, HW Nijman, T Daemen, ... Journal of Infectious Diseases 204 (3), 377-384, 2011 | 89 | 2011 |
| Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis MH Rozenbaum, AJ Van Hoek, D Fleming, CL Trotter, E Miller, ... Bmj 345, 2012 | 86 | 2012 |
| Cost–effectiveness of varicella vaccination programs: an update of the literature MH Rozenbaum, AJ Van Hoek, S Vegter, MJ Postma Expert review of vaccines 7 (6), 753-782, 2008 | 67 | 2008 |
| Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged≥ 65 years in the Netherlands MH Rozenbaum, E Hak, TS van der Werf, MJ Postma Clinical therapeutics 32 (8), 1517-1532, 2010 | 60 | 2010 |
| Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands MJ Meijboom, MH Rozenbaum, A Benedictus, W Luytjes, MCJ Kneyber, ... Vaccine 30 (31), 4691-4700, 2012 | 55 | 2012 |
| Low levels of RSV testing among adults hospitalized for lower respiratory tract infection in the United States MH Rozenbaum, J Judy, D Tran, K Yacisin, SK Kurosky, E Begier Infectious Diseases and Therapy 12 (2), 677-685, 2023 | 49 | 2023 |
| Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations S Vegter, MH Rozenbaum, R Postema, K Tolley, MJ Postma Clinical Therapeutics 32 (9), 1651-1661, 2010 | 49 | 2010 |
| Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden RE Lauppe, JL Hansen, C Gerdesköld, MH Rozenbaum, AM Strand, ... Open Heart 8 (2), e001755, 2021 | 48 | 2021 |
| Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world MJ Postma, M Jit, MH Rozenbaum, B Standaert, HA Tu, RCW Hutubessy BMC medicine 9, 1-11, 2011 | 48 | 2011 |
| Incidence of respiratory syncytial virus infection in older adults: limitations of current data MH Rozenbaum, E Begier, SK Kurosky, J Whelan, D Bem, KB Pouwels, ... Infectious diseases and therapy 12 (6), 1487-1504, 2023 | 47 | 2023 |
| Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model MH Rozenbaum, MJJ Mangen, C Giaquinto, JC Wilschut, E Hak, ... BMC Public Health 11, 1-12, 2011 | 46 | 2011 |
Albert Jan van HoekHealth economist / Infectious disease modeller, RIVMEmail được xác minh tại rivm.nl